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Protective effect of mulberry flavonoids on sciatic nerve in 
alloxan‑induced diabetic rats
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Mulberry leaves (Morus alba L.) are a traditional Chinese medicine for blood serum glucose reduction. 
This study evaluated the protective effects of mulberry flavonoids on sciatic nerve in alloxan-induced 
diabetic rats. In this study, 80 Sprague-Dawley rats were divided into five groups: A (control), B (diabetic 
treated with saline), C-D (diabetic treated with 0.3, 0.1 g/kg mulberry flavonoids once a day for 8 weeks) 
and E (diabetic treated with 0.3 mg/kg methycobal). The diabetic condition was induced by intraperitoneal 
injection of 200 mg/kg alloxan dissolved in saline. At the end of the experimental period, blood, and 
tissue samples were obtained for biochemical and histopathological investigation. Treatment with  
0.3 g/kg mulberry flavonoids significantly inhibited the elevated serum glucose (P< 0.01). The 
increased myelin sheath area (P< 0.01), myelinated fiber cross-sectional area and extramedullary fiber 
number (P< 0.05) were also reduced in alloxan-induced rats treated with 0.3 g/kg mulberry flavonoids.  
0.3 g/kg mulberry flavonoids also markedly decreased onion-bulb type myelin destruction and 
degenerative changes of mitochondria and Schwann cells. These findings demonstrate that mulberry 
flavonoids may improve the recovery of a severe peripheral nerve injury in alloxan-induced diabetic 
rats and is likely to be useful as a potential treatment on peripheral neuropathy (PN) in diabetic rats.
Uniterms: Morus alba L./pharmacognosy. Mulberry flavonoids/protective effects/experimental study. 
Diabetic neuropathy/experimental study. Medicinal plants. Diabetics/treatment/experimental study.
Folhas de amoreira (Morus alba L.) é um medicamento tradicional chinês para a redução da glicose no 
soro sanguíneo. Avaliaram-se, neste trabalho, os efeitos protetores dos flavonóides de amora no nervo 
ciático em ratos diabéticos aloxano-induzidos. Dividiram-se 80 ratos Sprague-Dawley em cinco grupos: 
A (controle), B (diabétidos tratados com solução salina), C-D (diabéticos tratados com 0,3, 0,1 g/kg) 
e E (diabéticos tratados com 0,3 mg de metilcobal).A diabetes foi induzida por injeção intraperitoneal 
de 200 mg/kg de aloxana dissolvida em solução salina. No final do período experimental, obtiveram-
se amostras de sangue e de tecido para investigação bioquímica e histopatológica. O tratamento com  
0,3 g/kg de flavonóides da amoreira inibiu, significativamente, a elevação de glicose no soro (p <0,01). 
O aumento da área da bainha de mielina (p <0,01), da área de fibra da seção transversal e do número 
de fibras mielinizadas extramedulares (p <0,05) foi também reduzido em ratos aloxânicos, tratados 
com 0,3 g/kg flavonóides de amora. Flavonóides da amoreira na dose de 0,3 g/kg também diminuiram, 
acentuadamente, a destruição da mielina do tipo bulbo de cebola e as alterações degenerativas das células 
mitocôndrias e das células de Schwann. Estes resultados demonstram que os flavonóides da amoreira 
podem melhorar a recuperação de uma lesão nervosa periférica grave em ratos com diabetes, induzida por 
aloxana, e parece ser útil como tratamento potencial para a neuropatia periférica (PN) em ratos diabéticos.
Unitermos: Morus alba L./farmacognosia. Flavonóides de amora/efeitos protetores/estudo experimental. 
Neuropatia diabética/estudo experimental. Plantas medicinais. Diabetes/tratamento/estudo experimental.
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INTRODUCTION
Diabetes mellitus (DM) is a major degenerative 
ailment in the world today, affecting at least 100 million 
people in China (Hu, Zhang, 2011) and resulting in severe 
metabolic imbalances and pathological changes in many 
tissues. Diabetic peripheral neuropathy (DPN) is one of 
the most common secondary complications of diabetes, 
which affects approximately 70-90% of the world’s 
population suffering from diabetes (Cow, 1997). The 
histopathology of the condition is characterized by axonal 
degeneration, demyelination, and atrophy in association 
with failed axonal regeneration, remyelination, and 
impaired synaptogenesis (Omran, 2012). Glucose control 
may prevent, stabilize, and even reverse neuropathy 
and other chronic diabetic complications (Ismail-
Beigi et al., 2010). Unfortunately, insulin therapy 
does not prevent the progression of chronic lesions 
in the nerves of the diabetic patient (Dandona et al., 
1985). Therefore, there is great interest in investigating 
other medicines to protect the peripheral nerves from 
damage.
In traditional Chinese medicine, several medicinal 
plants or their extracts are widely used to cure “Xiao-
ke” (diabetes) such as Mulberry leaves (Morus alba L.). 
Mulberry tree is widely grown throughout China. The 
extract from Mulberry leaves (Morus alba L.), especially 
flavonoids, has been demonstrated to have potential 
effect on oxidative stress (Naowaboot et al., 2009a), 
inflammation (Kim et al., 2012) and cardiovascular 
protection (Naowaboot et al., 2009b). Importantly, there 
has been scientific evidence showing that mulberry 
flavonoids has antihyperglycemic effects on patients 
with type 2 diabetes or diabetic animal model (Andallu, 
Varadacharyulu, 2002; Katsube et al., 2010) and protective 
effects on ocular functions of pups of diabetic rats (El-
Sayyad et al., 2011). However, to date there has not been a 
study to assess the role of mulberry flavonoids on diabetic 
peripheral neuropathy.
Since Mulberry leaf is a potent natural blood 
glucose lowing activity agent, it was hypothesized that 
it has a neuroprotective role on sciatic nerve in diabetic 
rats. Hence, this investigation was conducted to examine 
whether mulberry flavonoids may counteract the effects 
of alloxan on peripheral neuropathy, specifically sciatic 
nerve damage. To the best of our knowledge, this 
research is the first report on the effects of mulberry 
flavonoids on sciatic nerve in alloxan-induced diabetic 
rats, which may contribute to the development of new 
phytotherapies in counteracting peripheral neuropathy of 
diabetes.
MATERIAL AND METHODS
Drug and Animals
The dried Mulberry leaves were collected in 
Chengdu, the provincial capital of Sichuan province, 
in China. Mulberry flavonoids (purity>98% by HPLC, 
No. 100601) was extracted from dried Mulberry leaf by 
Chengdu Yiquan Science and Technology Development 
Co., Ltd. (Chengdu, China). Methycobal pill (No. 
101271A) was manufactured by Eisai Co., Ltd (Japan).
7-8 weeks Sprague-Dawley rats (male, n=40; 
female, n=40, respectively) weighing 180-220 g were 
purchased from the Experimental Animal Center of 
Chengdu University of Traditional Chinese Medicine 
(Chengdu, China). Animals were allowed free access to 
standard diet and sterile water in a restricted access room 
with temperature-controlled (20±1 °C) and humidity-
controlled (60±10%) rooms under 12 h light/dark. All the 
experimental procedures were performed in accordance 
with the guidelines of the Experimental Research Institute 
of Chengdu University of Traditional Chinese Medicine. 
Forty rats were included in this study after confirmation 
of success of diabetic models and randomly divided into 
5 groups: A (control), B (diabetic treated with saline), 
C (diabetic treated with 0.3 g/kg mulberry flavonoids, 
equivalent to 15 times of an adult human dosage), D 
(diabetic treated with 0.1 g/kg mulberry flavonoids, 
equivalent to 5 times of an adult human dosage) and E 
(diabetic treated with 0.3 mg/kg methycobal, equivalent 
to 10 times of an adult human dosage); each group contain 
ten animals.
Induction of diabetes
Diabetes rat model was induced in B-E group by 
intraperitoneal injection of alloxan dissolved in saline at 
the dose of 100 mg/kg body weight, twice a day. Control 
rats were injected with the same volume of saline as the 
diabetic animals that received alloxan. The serum glucose 
levels of each of the rats were checked everyday from 
the 3rd day with glucose oxidase method. After 5 days, 
animals with serum glucose levels of 16.7 mmol/L and 
above were considered to be diabetic and were used for the 
study. Serum glucose levels in control animals remained 
normal for the duration of the study.
The rats in B-E groups were given corresponding 
drug once a day orally for 8 weeks starting 5 days after 
alloxan injection, respectively. Control rats were given 
the same volume of saline once a day orally for 8 weeks. 
The initial and final body weight changes of the various 
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TABLE I - Changes of rats’ fasting blood glucose (FBG) and body Weight (BW) before/after the 8 weeks treatment (–x ±s, n=10)
Group
Dosage 
(mg/kg)
FBG (mmol/L) BW (g) 
before after before after
Control (A) — 5.54±1.10 6.01±1.13 182.64±12.18 391.3±11.2
Diabetic model (B) — 22.51±2.36** 19.86±3.89** 195.87±5.46 286.5±34.5**
Mulberry flavonoids (C) 300 21.67±2.32**  16.01±2.41** 194.45±4.41 358.7±36.2*#▲
Mulberry flavonoids (D) 100 22.30±3.10** 18.12±2.65** 190.12±9.85 319.4±41.3**
Methycobal (E) 0.3 21.82±3.69** 18.35±3.10** 194.68±7.76 322.7±35.2**
*P<0.05, **P<0.01 vs group A; P<0.05, P<0.01 vs group B; ▲P<0.05 vs group D; # P<0.05, ## P<0.01 vs group E
groups were recorded. Blood samples were collected by 
orbital venous and the initial and final serum glucose levels 
of the various groups were measured by glucose oxidase 
method. Segments of the right sciatic nerve were obtained 
from each rat after anaesthetized with 4% pentobarbital 
(25 mg/kg, i.p) and used for light and electron microscopy.
Histopathological examination
Sciatic nerve was fixed in 10% (v/v) neutral-
buffered formalin for 24 h at 4 °C. Tissues were embedded 
in paraffin, sectioned at 4 μm thickenss, and stained 
with chromotrope 2R-brilliant green solution. In the 
sciatic nerve, the myelin sheath area, myelinated fiber 
cross-sectional area and extramedullary fiber area were 
quantified using MIAS2000 software.
Electron microscopy
For electron microscopy, sciatic nerves specimens 
were fixed with 3% glutaraldehyde in 0.1 M sodium 
phosphate buffer (pH 7.2) for 3 h at 4 °C, washed in the 
same buffer for 1h at 4 °C and post-fixed with 1% osmium 
tetraoxide in sodium phosphate buffer for 1h at 4 °C. The 
tissues were then dehydrated in graded series of acetone 
and embedded in Epon812. Ultrathin sections (60 nm) 
were stained with both lead citrate and uranyl acetate 
for the transmission electron microscope (H-600IV, 
Japan) evaluation. Seven different images from each 
specimen were taken to calculate myelinated fibre area 
and density using an image analysis system (Image-Pro 
Plus 6.1, Media Cybernetics, Silver Spring, MD, USA). 
The investigator was blind to group identity during the 
morphometry process.
Statistical analysis
Values are presented as means ± standard deviation. 
Statistical significance was determined by one-way 
ANOVA and Student’s t-test using SPSS13.0 for Windows. 
P<0.05 was considered to indicate statistical significance.
RESULTS
Effect of mulberry flavonoids on blood glucose 
level and body weight in diabetic rats
Blood glucose level and body weight were shown in 
Table I. The baseline weights of the rats at the beginning 
of the study were similar in all groups. The diabetic 
animals exhibited obviously decreased body weight and 
consistently hyperglycaemia relative to non-diabetic 
controls (P<0.01) (Table I). Treatment with 0.3g/kg 
mulberry flavonoids caused a visible decrease in the 
elevated serum glucose (P<0.05) in alloxan induced 
diabetic rats and a significantly difference in weight gain 
compared to the model group (P<0.01) (Table I).
Effects of mulberry flavonoids on morphological 
changes of myelinated fiber of sciatic nerve
The myelin sheath area and myelinated fiber cross-
sectional area were decreased in diabetic rats (group 
B) compared with control rats (group A) and these 
changes were alleviated by mulberry flavonoids (group 
C, D) and methycobal (group E). Likewise, the average 
optical density of myelin sheath area and myelinated 
fiber cross-sectional area were decreased in diabetic rats 
(group B) compared with control rats (group A) and these 
changes were also alleviated by mulberry flavonoids and 
methycobal administration (P <0.05 or 0.01; Table II).
Effects of mulberry flavonoids on extramedullary 
fiber of sciatic nerve
In control rats, histology of sciatic nerves was 
normal (Figure 1A). The extramedullary fiber number 
in diabetic rats was significantly less than in control rats 
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(Figure 1B), whereas the numbers of extramedullary fiber 
of sciatic nerves were markedly increased in group C-E 
(Figures 1C, 1D and 1E), especially mulberry flavonoids 
treated groups (Figure 1C). The same results can be 
obtained by quantified using MIAS2000 software. In 
diabetic rats, the extramedullary fiber area and AOD were 
significantly reduced compared with control rats. Treated 
with mulberry flavonoids and methycobal can alleviate 
these changes (P < 0.05 or 0.01; Table III).
Effects of mulberry flavonoids on changes of 
ultrastructural of sciatic nerve
Ultrastructural evaluation of sciatic nerves 
confirmed the light microscopy findings. The sciatic 
nerves in control group showed normal structure 
(Figure 2A). Sciatic nerve electron micrograph of 
diabetic rats shows shrunken axons, myelin destructions 
with onion-bulb form protrusion on the myelin sheath 
TABLE II - Changes of the myelin sheath area and myelinated fiber cross-sectional area of rat’s sciatic nerve (–x ±s, n=10)
Group
Dosage 
(mg/kg)
myelin sheath area 
(μm)
AOD of myelin 
sheath area
myelinated fiber 
cross-sectional area 
(μm)
AOD of myelinated 
fiber cross-sectional 
area
Control (A) — 87.70±13.53 181.74±13.80 4311.09±975.53 288.45±29.10
Diabetic model (B) — 60.43±8.34** 152.38±8.59** 2387.08±1101.25** 192.38±17.59**
Mulberry flavonoids (C) 300 82.36±5.01 178.92±11.66 3776.58±885.45 260.91±22.54*#
Mulberry flavonoids (D) 100 77.45±7.64 168.42±11.45 3418.23±976.56 240.85±18.34*
Methycobal (E) 0.3 71.49±9.03* 168.31±8.22 3015.12±897.24* 230.31±18.56**
*P<0.05,**P<0.01 vs group A; P<0.05, P<0.01 vs group B; # P<0.05, ## P<0.01 vs group E
FIGURE 1 - Histology of the sciatic nerve of each experimental rat by staining with chromotrope 2R-brilliant green (×200) (A) 
Control rats. (B) Diabetic neuropathy rats. (C) Diabetic neuropathy rats treated with 0.3 g/kg mulberry flavonoids. (D) Diabetic 
neuropathy rats treated with 0.1 g/kg mulberry flavonoids. (E) Diabetic neuropathy rats treated with methycobal.
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TABLE III - Change of extramedullary fiber of rat’s sciatic nerve (–x ±s, n=10)
Group Dosage (mg/kg) Area (μm) AOD
Control (A) — 78.69±7.53 188.21±9.30
Diabetic model (B) — 56.41±10.25** 152.38±7.59**
Mulberry flavonoids (C) 300 69.36±7.11# 178.92±11.66
Mulberry flavonoids (D) 100 63.24±8.64* 170.12±8.45
Methycobal (E) 0.3 66.54±7.03* 167.31±8.54
*P<0.05, **P<0.01 vs group A; P<0.05, P<0.01 vs group B; # P<0.05, ## P<0.01 vs group E
and the axonal myelins were vacuolization and lamellar 
separation. Degenerative changes were also observed in 
mitochondria and Schwann cells (Figure 2B). Histologic 
evaluation of the tissues in animals pretreated with 
0.3 g/kg mulberry flavonoids showed ultrastructural 
features of myelin and axons remarkable improved and 
myelin breakdown decreased markedly (Figure 2C). 
Likewise, vacuolization and lamellar separation of the 
FIGURE 2 - Representative transmission electron micrographs showing the ultrastructure of sciatic nerves (×7000) (A) Control 
rats: intact myelinated axon. (B) Diabetic neuropathy rats: serious demyelination. (C) Diabetic neuropathy rats treated with 
0.3 g/kg mulberry flavonoids: tiny segmental demyelination and local axon separation from sheaths is seen. (D) Diabetic neuropathy 
rats treated with 0.1 g/kg mulberry flavonoids: mild axon separation from the sheaths is seen. (E) Diabetic neuropathy rats treated 
with methycobal: mild axon separation from the sheaths is seen.
axonal myelin was less obvious. The fine structure of 
Schwann cells was seemingly normal.
DISCUSSION
The present study is the first to demonstrate that 
mulberry flavonoids had potent neuroprotective effects on 
sciatic nerve in alloxan-induced diabetic rat model, which 
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led to improvement of myelinated fiber and extramedullary 
fiber. Ultrastructural evaluation of sciatic nerves confirmed 
that mulberry flavonoids restored the axonal degeneration 
and demyelination.
Alloxan is one of the usual substances used to 
induce diabetes mellitus. It caused pancreatic β cells 
sufficient damage thus resulted to a notable increase in 
blood glucose levels (Verma et al., 2010). In our study, 
we first evaluated the antidiabetic activity of mulberry 
flavonoids in alloxan-induced diabetic rats by testing 
fasting blood glucose level by glucose oxidase method. 
Our findings, in accordance with earlier studies, indicate 
that treatment with 0.3 g/kg mulberry flavonoids (equal 
to 15-fold the clinic dosage) significantly inhibit the 
alloxan-induced hyperglycemia of rats. On the other 
hand, our results also indicated that 0.3 g/kg mulberry 
flavonoids caused a significantly difference in weight 
gain compared to the model group.
As the most common secondary complications 
of diabetes, DPN is characterized by progressive 
axons loss in humans (Calcutt, Backonja, 2007). Axon 
demyelination and loss were also presented in the 
sciatic nerve of diabetic mice by electron microscopy 
examination (Kang et al., 2011). The proper function 
and maintenance of axons depended on myelin formation 
(Lappe-Siefke et al., 2003). Consequently, myelin 
loss results in pathological conditions, such as DPN. 
Moreover, the axon degeneration is relation with 
pathogenesis of negative signs of DPN (Thomas, 
1999). As reported before (Veiga et al., 2006), the most 
abundant nerve abnormality observed in our study was 
that both myelinated fiber and extramedullary fiber of the 
sciatic nerve were markedly decreased in diabetic rats, 
as opposed to the control group.
Flavonoids extracted from Mulberry leaves (Morus 
alba L.) were described for anti-diabetes effects in rats 
(Singab et al., 2005) and demonstrated marked intestinal 
maltase inhibitory activity (Adisakwattana et al., 2012) 
in vitro. In this study, we further evaluated the role of 
mulberry flavonoids on diabetic peripheral neuropathy 
in rat, and our morphological study of sciatic nerve 
revealed that administration of mulberry flavonoids, 
especially at the dose of 0.3 g/kg, notably increased the 
area of myelinated fiber and number of extramedullary 
fiber to close to the control group. Schwann cells, which 
are susceptible to hyperglycemia, play a crucial role in 
maintenance of peripheral nerve myelin. The sciatic nerve 
electron micrograph of diabetic rats in the present result 
shows degenerative changes of Schwann cells, onion-
bulb type myelin destructions and lamellar separation. 
With 0.3 g/kg mulberry flavonoids treatment, the axonal 
and Schwann cells degeneration were ameliorated, too.
In conclusion, we show that 0.3 g/kg mulberry 
flavonoids exert a substantial protective effect against 
alloxan-induced diabetic neuropathy in sciatic nerve of 
rats. These findings provide a therapeutic potential for 
future treatment of diabetic peripheral neuropathy.
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